Genistein directly inhibits native and recombinant NMDA receptors

Neuropharmacology

Volumn 58, Issue 8, 2010, Pages 1246-1251

  Huang, Renqi ^a   Singh, Meharvan ^a   Dillon, Glenn H ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; GENISTEIN; LAVENDUSTIN A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECOMBINANT RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL STRAIN HEK293; CONCENTRATION PROCESS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; GENISTEIN; HIPPOCAMPUS; ION CHANNEL GATING; ISOFLAVONES; MICE; MICE, INBRED C57BL; PATCH-CLAMP TECHNIQUES; PHENOLS; PROTEIN-TYROSINE KINASES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS;

EID: 77952872947     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.03.006     Document Type: Article

References (44)

1. Akiyama T., Ogawara H. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 1991, 201:362-370.
2. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262:5592-5595.
3. Ali D.W., Salter M.W. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr. Opin. Neurobiol. 2001, 11:336-342.
4. Belevych A.E., Warrier S., Harvey R.D. Genistein inhibits cardiac L-type Ca(2+) channel activity by a tyrosine kinase-independent mechanism. Mol. Pharmacol. 2002, 62:554-565.
5. Bertrand D., Devillers-Thiery A., Revah F., Galzi J.L., Hussy N., Mulle C., Bertrand S., Ballivet M., Changeux J.P. Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:1261-1265.
6. Blevins T., Mirshahi T., Chandler L.J., Woodward J.J. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells. J. Neurochem. 1997, 69:2345-2354.
7. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
8. Casey M., Maguire C., Kelly A., Gooney M.A., Lynch M.A. Analysis of the presynaptic signaling mechanisms underlying the inhibition of LTP in rat dentate gyrus by the tyrosine kinase inhibitor, genistein. Hippocampus 2002, 12:377-385.
9. Chen B.S., Roche K.W. Regulation of NMDA receptors by phosphorylation. Neuropharmacology 2007, 53:362-368.
10. Choi D.W. Excitotoxic cell death. J. Neurobiol. 1992, 23:1261-1276.
11. Collett V.J., Collingridge G.L. Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells. Br. J. Pharmacol. 2004, 142:991-1001.
12. Cull-Candy S.G., Leszkiewicz D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci. STKE 2004, 16.
13. Dean J.B., Huang R.Q., Erlichman J.S., Southard T.L., Hellard D.T. Cell-cell coupling occurs in dorsal medullary neurons after minimizing anatomical-coupling artifacts. Neuroscience 1997, 80:21-40.
14. Dunne E.L., Moss S.J., Smart T.G. Inhibition of GABAA receptor function by tyrosine kinase inhibitors and their inactive analogues. Mol. Cell Neurosci. 1998, 12:300-310.
15. Gahwiler B. Organotypic monolayer cultures of nervous tissue. J. Neurosci. Methods 1981, 4:329-342.
16. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 1996, 271:695-701.
17. Hsu C.Y., Persons P.E., Spada A.P., Bednar R.A., Levitzki A., Zilberstein A. Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue. J. Biol. Chem. 1991, 266:21105-21112.
18. Huang R.Q., Dillon G.H. Direct inhibition of glycine receptors by genistein, a tyrosine kinase inhibitor. Neuropharmacology 2000, 39:2195-2204.
19. Huang C.C., Hsu K.S. Protein tyrosine kinase is required for the induction of long-term potentiation in the rat hippocampus. J. Physiol. 1999, 520(Pt 3):783-796.
20. Huang R.Q., Fang M.J., Dillon G.H. The tyrosine kinase inhibitor genistein directly inhibits GABAA receptors. Brain Res. Mol. Brain Res. 1999, 67:177-183.
21. Huang R.Q., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J. Pharmacol. Exp. Ther. 2001, 298:986-995.
22. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
23. Kurejova M., Lacinova L. Effect of protein tyrosine kinase inhibitors on the current through the Ca(V)3.1 channel. Arch. Biochem. Biophys. 2006, 446:20-27.
24. Lynch J.W., Rajendra S., Barry P.H., Schofield P.R. Mutations affecting the glycine receptor agonist transduction mechanism convert the competitive antagonist, picrotoxin, into an allosteric potentiator. J. Biol. Chem. 1995, 270:13799-13806.
25. Malenka R.C., Nicoll R.A. Long-term potentiation-a decade of progress?. Science 1999, 285:1870-1874.
26. Nichols M.R., Morimoto B.H. Tyrosine kinase-independent inhibition of cyclic-AMP phosphodiesterase by genistein and tyrphostin 51. Arch. Biochem. Biophys. 1999, 366:224-230.
27. O'Dell T.J., Kandel E.R., Grant S.G. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 1991, 353:558-560.
28. Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun. 1988, 157:183-189.
29. Paillart C., Carlier E., Guedin D., Dargent B., Couraud F. Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 1997, 280:521-526.
30. Pan W., Ikeda K., Takebe M., Yamori Y. Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats. J. Nutr. 2001, 131:1154-1158.
31. 2+ influx and glutamate release from hippocampal synaptosomes: putative non-specific effects. Neurochem. Int. 2003, 42:179-188.
32. Peterson G. Evaluation of the biochemical targets of genistein in tumor cells. J. Nutr. 1995, 125:784S-789S.
33. Sans N., Petralia R.S., Wang Y.X., Blahos J., Hell J.W., Wenthold R.J. A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J. Neurosci. 2000, 20:1260-1271.
34. Singh M., Setalo G., Guan X., Frail D.E., Toran-Allerand C.D. Estrogen-induced activation of the mitogen-activated protein kinase cascade in the cerebral cortex of estrogen receptor-alpha knock-out mice. J. Neurosci. 2000, 20:1694-1700.
35. Smirnov S.V., Aaronson P.I. Inhibition of vascular smooth muscle cell K+ currents by tyrosine kinase inhibitors genistein and ST 638. Circ. Res. 1995, 76:310-316.
36. Tao J., Zhang Y., Li S., Sun W., Soong T.W. Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction. Cell Calcium 2009, 45:133-143.
37. Tikkanen M.J., Wahala K., Ojala S., Vihma V., Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3106-3110.
38. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
39. Wang Y.T., Salter M.W. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 1994, 369:233-235.
40. Wang Y.T., Yu X.M., Salter M.W. Ca(2+)-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1721-1725.
41. Whitechurch R.A., Ng K.T., Sedman G.L. Tyrosine kinase inhibitors impair long-term memory formation in day-old chicks. Brain Res. Cogn. Brain Res. 1997, 6:115-120.
42. Yamashita Y., Kawada S., Nakano H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem. Pharmacol. 1990, 39:737-744.
43. Yokoshiki H., Sumii K., Sperelakis N. Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J. Mol. Cell Cardiol. 1996, 28:807-814.
44. Zhu L., Jiang Z.L., Krnjevic K., Wang F.S., Ye J.H. Genistein directly blocks glycine receptors of rat neurons freshly isolated from the ventral tegmental area. Neuropharmacology 2003, 45:270-280.